Nov 18, 2024, 18:06 | Career

Jason Westin is running for the Board of Directors of ASCO

Jason Westin is a candidate for a position on the Board of Directors for ASCO.…

Nov 15, 2024, 16:49 | Blog

Long-Term Outcomes of Mini-CHOP Plus Anti-CD20 in Elderly DLBCL Patients

Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared…

Nov 13, 2024, 14:55 | Blog

Krish Patel has been appointed as the New Director of Lymphoma Research at SCRI

Sarah Cannon Research Institute (SCRI), a global leader in oncology research and community-based clinical trials,…

Nov 12, 2024, 16:11 | Blog

Yasmina Serroukh Shares Poster on SCT for Marginal Zone Lymphoma

Yasmina Serroukh, Hematologist at Erasmus MC, posted on X: “I am thrilled to share our work…

Nov 10, 2024, 16:55 | Blog

A Teen’s Story of Hope and Support from The Leukemia and Lymphoma Society

The Leukemia & Lymphoma Society posted the following on X: “'Fast forward two years, I…

Nov 9, 2024, 10:59 | Blog

Applications open for the 7th Cohort of the Certificate of Advanced Studies in Lymphomas - European School of Oncology

European School of Oncology shared a post on LinkedIn: "Have you ever considered expanding your…

Oct 25, 2024, 16:34 | Insight

Three decades of pioneering in Immune Oncology - Agenus

Agenus Inc. is a biopharmaceutical company and a prominent leader in the field of immuno-oncology,…

Oct 22, 2024, 15:49 | Blog

Mulham Ombada: My first E-Poster presentation at LLM Congress 2024

Mulham Ombada, Internal Medicine Residency at Upstate Medical University, shared a post on X: My first E-Poster presentation!…

Oct 21, 2024, 12:43 | Blog

Mark Bustoros: Great debate about whether CAR-T could replace autotransplant as consolidation

Mark Bustoros, Physician-scientist, Assistant Professor at Weill Cornell Medicine, shared on X: ''Great debate and overview…

Oct 19, 2024, 11:24 | Blog

That’s a wrap on day 2 of Lymphoma, Leukemia & Myeloma Congress

Lymphoma, Leukemia & Myeloma Congress posted the following on X: “That’s a wrap on day…

Oct 17, 2024, 16:20 | Insight

Aaron Goodman: One of my favorite differentials, Intestinal T/NK lymphoma

Aaron Goodman, Associate Professor of Medicine at the University of California, San Diego, shared a…

Oct 16, 2024, 14:30 | Blog

Programme Highlight Of ESH Lymphoma 2024

European School of Haematology shared a post on X: "PROGRAMME HIGHLIGHT OF ESH LYMPHOMA 2024: 3…

Oct 11, 2024, 15:13 | Insight

Aggressive Lymphoma after CD19 CAR T-Cell Therapy suggested by Vivek Subbiah

Vivek Subbiah shared a post on X: "Aggressive Lymphoma after CD19 CAR T-Cell Therapy clonal hematopoiesis…

Oct 8, 2024, 14:00 | Blog

Yan Leyfman: 2 weeks until the Lymphoma, Leukemia and Myeloma Congress

Yan Leyfman shared a post on LinkedIn: "Just 2 weeks until I'm attending the Lymphoma, Leukemia…

Oct 7, 2024, 11:25 | Blog

Jeff Sharman: Reflecting on the incredible progress made in lymphoma research

Jeff Sharman, Medical Director for Hematology Research at US Oncology, shared a post on LinkedIn,…

Oct 6, 2024, 12:47 | Insight

Bouthaina Dabaja: Target nomenclature for lymphoma trials

Bouthaina Dabaja, Radiation Oncologist at MD Anderson Cancer Center, shared a post on X about…

Oct 4, 2024, 10:05 | Blog

Meet the faculty members of ESH Lymphoma 2024 - ESH (Haematology)

ESH (Haematology) shared a post on X: "MEET THE FACULTY MEMBERS OF ESH LYMPHOMA 2024. REGISTER…

Sep 26, 2024, 17:47 | Insight

Charles Gaulin: Our initiative on enhancing advance care planning has received an ASCO Conquer Cancer Merit Award

Charles Gaulin shared a post on LinkedIn: "Excited to announce that our quality improvement initiative…

Sep 23, 2024, 13:49 | Blog

Africa Cancer Foundation - Lymphoma is a broad term for cancer that begins in cells of the lymph system

Africa Cancer Foundation shared on X: ''The lymphatic system is part of the immune system…

Sep 22, 2024, 13:59 | Blog

Lymphoma is a broad term for cancer that begins in cells of the lymph system - Africa Cancer Foundation

Africa Cancer Foundation shared a post on X: "The lymphatic system is part of the…

Sep 13, 2024, 23:49 | Blog

Naveen Pemmaraju: Wonderful to attend the highly successful SOHO2024 meeting

Naveen Pemmaraju posted the following on LinkedIn: “Wonderful to attend the highly successful SOHO2024 meeting held…

Sep 13, 2024, 14:17 | Opinion

Sendurai Mani: A walk to bring awareness for Cancer and early detection to save lives

Sendurai Mani shared on Linkedin: ''On September 7th, 2024, in honor of cancer survivors, to…

Sep 10, 2024, 13:56 | Blog

Aren Karapetyan: I highlighted my poster presentation on Patterns of Radiotherapy for Lymphoma in Armenia at SOHO 2024

Aren Karapetyan, Medical Resident at Yerevan State Medical University named after Mkhitar Heratsi and Secretary…

Sep 7, 2024, 10:11 | Insight

Cancer-Related Fatigue in Patients and Survivors of Lymphoma by Steve Kalloger et al.

AACR Journals shared on LinkedIn: “Cancer-related fatigue is often underreported and poorly understood. Check out…

Sep 5, 2024, 05:09 | Blog

Joshua Brody: Excited for the CME event on CAR T-cell therapy for lymphoma and CLL at SOHO2024

Joshua Brody shared on LinkedIn: "Excited for the Amps-to-go-up-to-11 at tomorrow's CME event on CAR…

Sep 4, 2024, 15:50 | Blog

Shreevikaa Kannan: The challenges of CAR-T therapies in T-cell lymphoma by Jasmine Zain

Shreevikaa Kannan, Head of TSMU academic department, shared on LinkedIn: "Don't miss the opportunity to hear…

Aug 27, 2024, 22:40 | Insight

Raul Cordoba: CART cell therapy is a feasible treatment option for older patients with lymphoma

Raul Cordoba shared a paper by Rebeca Bailén et al. on X: "CART cell therapy…

Aug 27, 2024, 13:04 | Blog

August 26 is the International Dog Day!

August 26 is International Dog Day, a time to celebrate the joy, loyalty, and companionship…

Aug 25, 2024, 16:05 | Insight

Kimryn Rathmell: ViPOR regimen is helping more B-cell lymphoma patients achieve full remission

Kimryn Rathmell shared a post on X: "A new NCI study shows the ViPOR regimen,…

Aug 23, 2024, 06:22 | Blog

Highlights from the 2024 Seattle Cellular Therapy Summit

The 2024 Seattle Cellular Therapy Summit will feature leading experts who will provide a detailed…

Aug 20, 2024, 14:29 | Blog

Rahul Banerjee: What's the best unifying term for the equivalent of bridging therapy but before apheresis?

Rahul Banerjee shared a poll on X: "Maybe more of a CAR-T consensus here than…

Aug 15, 2024, 04:56 | Blog

Hung Trinh: A novel CAR-Enhancer to prevent relapse after CAR-T Therapy by Dana-Farber Cancer Institute

Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…

Aug 12, 2024, 13:10 | Insight

Matt Wilson: Updated good practice paper on CNS prophylaxis in LBCL

Matt Wilson, Consultant Haematomogist specialising in lymphoma at The Beatson West of Scotland Cancer Centre,…

Aug 9, 2024, 10:21 | Insight

Immunotherapy with chemo improves survival for aggressive relapsed lymphoma

Joshua Brody, Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at…

Aug 9, 2024, 05:13 | Insight

Krishna Komanduri: CMV reactivation after CAR-T therapy for lymphoma

Recently, an article by Rick Lin et al. titled "Incidence and outcomes of cytomegalovirus reactivation…

Aug 5, 2024, 11:50 | Blog

Annals of Research in Oncology - Case study on extranodal non-Hodgkin B-cell marginal zone lymphoma

Annals of Research in Oncology shared on LinkedIn: "New case study on Lymphoma in Parotid Gland…

Aug 4, 2024, 09:41 | Insight

Michael Jain: 5-year outcomes of standard-of-care Axicabtagene Ciloleucel in lymphoma patients

Michael Jain, Oncologist at Moffitt Cancer Center, shared on X: "What is important for long-term…

Jul 28, 2024, 12:41 | Blog

Mohamed Kharfan-Dabaja: Great overview on management of indolent lymphomas by Urshila Durani

Mohamed Kharfan-Dabaja, Vice Chair of Hematology at Mayo Clinic Comprehensive Cancer Center, shared a post…

Jul 26, 2024, 19:54 | Career

Juan Rangel: I’m officially a Lymphoma/ASCT doctor after my fellowship at Princess Margaret Hospital

Juan Rangel, Lymphoma/ASCT doctor at Princess Margaret Hospital, shared on X: "I’m officially a Lymphoma/ASCT…

Jul 24, 2024, 08:12 | Insight

Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma

Nature Medicine shared on X about a paper titled "A systematic review and meta-analysis of nonrelapse…

Jul 22, 2024, 14:33 | Career

Sharon Castellino has been appointed to the board of directors of The Leukemia and Lymphoma Society - Winship Cancer Institute

Winship Cancer Institute of Emory University shared a post on LinkedIn: "Winship pediatric hematologist Sharon…

Jul 21, 2024, 11:37 | Blog

Ruben Mesa: ASCO overview of advances in lymphoma

Ruben Mesa shared on LinkedIn: "Our amazing Chair of Hematology and world expert in lymphoma Nilanjan…

Jul 18, 2024, 00:18 | Insight

Joshua Brody: Impressive potency of chemo-free immunotherapy as 1st-line treatment for lymphoma

Joshua Brody, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute, shared on…

Jul 15, 2024, 21:23 | Insight

Jason Yongsheng Chan: Cancer Discovery Hub's collaboration with Illumina focusing on Asian lymphomas occuring in younger patients

Jason Yongsheng Chan, Platform Lead at Singapore Translational Cancer Consortium, shared a post by Mynn…

Jul 13, 2024, 09:41 | Insight

IMMONC - Immune Oncology Research Institute's Experience in Advancing Clinical Cancer Research in Armenia

Cancer affects people across the world regardless of their socioeconomic status. However, low- and middle-income…

Jul 12, 2024, 21:49 | Blog

Q&A with Sarcoma Researcher and Oncologist Gina D’Amato - Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center shared on LinkedIn: "Dr. Gina D’Amato is medical oncologist treating sarcoma at…

Jul 10, 2024, 06:37 | Insight

Paul Bröckelmann: You don't see a study on Hodgkin Lymphoma published in Science Magazine everyday

Paul Bröckelmann, Physician Scientist at MPI for Biology of Ageing, shared on X: "You don't…

Jul 8, 2024, 17:31 | Insight

Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality

Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…

Jun 19, 2024, 22:16 | Blog

Michael Wang: An international randomized phase 3 trial is a huge undertaking

Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…

Jun 19, 2024, 12:19 | Blog

Oncology Advance - See this month’s highlights from the ESMO portfolio

Oncology Advance shared a post on X: "See this month’s highlights from the ESMO portfolio. Featured…

Jun 19, 2024, 06:53 | Insight

Raul Cordoba: Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma

Raul Cordoba shared on X: "HOT OFF THE PRESS! Epcoritamab monotherapy in patients with relapsed…

Jun 19, 2024, 01:26 | Blog

Ami Patel: An honor to work with Naveen Pemmaraju on MPN review article

Ami Patel, Hematologist at Huntsman Cancer Institute, shared a post by Naveen Pemmaraju on X, adding: “An…

Jun 18, 2024, 16:51 | Blog

Raul Cordoba: Very happy to provide mentorship to Young EHA members

Raul Cordoba, Head of the Lymphoma Unit at the Fundacion Jimenez Diaz University Hospital, Madrid,…

Jun 18, 2024, 10:27 | Insight

Naveen Pemmaraju: Our brand new MPN state-of-the-art review paper

Naveen Pemmaraju shared on LinkedIn: . "Super excited to share our brand…

Jun 18, 2024, 04:43 | Blog

Ruben Mesa: Wonderful work by Nilanjan Ghosh at EHA2024

Ruben Mesa shared a post by Nilanjan Ghosh, Chair of Department of Hematologic Oncology and…

Jun 16, 2024, 14:53 | Blog

Dr. Kami Maddocks is a OSUCCC – James Cancer Hospital Excellence Award winner - OSU Hematology

OSU Hematology recently shared a post on X: "Last month, the OSUCCC – James Cancer…

Jun 14, 2024, 13:42 | Blog

Ruben Mesa: Dr Nilanjan Ghosh raising over $300,000 at The Leukemia and Lymphoma Society 'Visionary of the Year'

Ruben Mesa shared on LinkedIn: . "So proud…

Jun 13, 2024, 06:51 | Insight

Racial disparities among patients treated with CART-cell therapy for lymphoma - Penn Medicine

Penn Medicine shared a post on X: “A new NEJM Evidence study found racial disparities…

Jun 11, 2024, 14:59 | Insight

Timos Papagatsias: EHA24 is expected to be one of the most exciting EHA conferences to-date!

Timos Papagatsias, CEO of LucidQuest shared a post on LinkedIn: “EHA24 is fast approaching and…

May 28, 2024, 06:38 | Blog

Soon Thye Lim: It’s not every day that you get news that your research team will be awarded S$25 million

Soon Thye Lim, Chief Executive Officer at National Cancer Centre Singapore, shared a post on LinkedIn: "It’s…

May 28, 2024, 00:56 | Insight

Pallawi Torka: Excited to attend ASCO24 next week and represent Memorial Sloan Kettering Cancer

Pallawi Torka, Assistant Attending at Memorial Sloan Kettering Cancer, shared a post on X: “Excited…

May 26, 2024, 11:34 | Insight

Krishna Komanduri: Congrats to Sattva Neelapu and colleagues for this correlative study on CAR-T cell fitness and function in lymphoma

Krishna Komanduri, Physician-in-Chief at the Helen Diller Family Comprehensive Cancer Center, shared a post by…

May 26, 2024, 01:41 | Blog

Institute of Molecular and Cell Biology part of two recently awarded NRF OF-LCG projects led by National Cancer Centre Singapore

Institute of Molecular and Cell Biology shared a post on LinkedIn: "Making an impact on patients'…

May 25, 2024, 13:26 | Societies

MD Anderson Cancer Center researchers will showcase the latest breakthroughs in cancer care at the 2024 ASCO Annual Meeting

MD Anderson Cancer Center shared on LinkedIn: "MD Anderson researchers will showcase the latest breakthroughs…

May 24, 2024, 13:11 | Blog

Kelley Wood: We observed significant improvements in Quality of Life across 12 different cancer types

Kelley Wood, Research Director at ReVital Cancer Rehab, made the following post on LinkedIn: “NEW PUB…

May 21, 2024, 12:00 | Blog

Michael Wang: Mechanisms of Senescence‑Associated Drug Resistance in Lymphoma

Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…

May 20, 2024, 15:34 | Blog

Alessandra Curioni Fontecedro: Gaëlle Rhyner is a fantastic colleague fully dedicated to patients and head of Lymphoma group

Alessandra Curioni Fontecedro, Head of Medical Oncology at the HFR Fribourg – Cantonal Hospital, shared…

May 18, 2024, 04:46 | Blog

Douglas Flora: Wonderful start to the day at The Leukemia and amp; Lymphoma Society’s Light The Night executive breakfast

Quoting Douglas Flora’s post on LinkedIn: “Had a wonderful start to the day at The Leukemia…

May 16, 2024, 14:09 | Societies

Join European School of Oncology’s webinar, ‘An Update: The Best of ASH in Lymphomas’

European School of Oncology shared on LinkedIn: “Exciting News! Join us for today's webinar: ‘An…

May 15, 2024, 12:22 | Blog

The Babak Lab - Exciting Progress in Melanoma Treatment: Personalized Vaccines Show Promise

Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared a post…

May 11, 2024, 13:57 | Blog

Michelle Tucker’s inspiring story of becoming a nurse - Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared on LinkedIn: "Michelle Tucker, BSN, RN, (right) wanted to be a nurse…

Apr 29, 2024, 00:16 | Insight

Kate Cwynarski: Wonderful talk by Philippe Gaulard

Kate Cwynarski, Haematogist-Oncologist in Lymphoma and CLL at University College London Hospital, shared on X/Twitter:…

Apr 25, 2024, 20:01 | Blog

Naveen Pemmaraju: Serious meeting of the heme minds today with Prof. Naveen Pemmaraju and Prof. Jason Westin

Naveen Pemmaraju shared on X: "Co-fellows to Co-Professors together at MD Anderson Cancer Center! Serious…

Apr 22, 2024, 01:02 | Career

Christopher Strouse Received the 2023 Donald D. Dorfman Award for lymphoma research - Internal Medicine at Iowa

Internal Medicine at Iowa shared on X/Twitter: "Clinical Assistant Professor of Internal Medicine Christopher Strouse,…

Apr 9, 2024, 17:56 | Insight

Myeloma Paper of the Day - Robert Z. Orlowski

Robert Z. Orlowski, Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma…

Apr 9, 2024, 17:16 | Positive

Raul Cordoba: Spent great times working with Mandy Lauw

Raul Cordoba, Head of the Lymphoma Unit at the Fundacion Jimenez Diaz University Hospital, shared…

Apr 8, 2024, 08:41 | Insight

Elizabeth Budde: We reported the longest follow-up of using BsAbs in lymphoma

Elizabeth Budde, Associate Professor at City of Hope, shared on X/Twitter: "We reported the longest…

Apr 2, 2024, 05:25 | Blog

Marco Davila: Had a great time hosting Michael Jain to give a powerhouse Medicine Grand Rounds at Roswell Park

Marco Davila, SVP and Associate Cancer Center Director of Translational Research at Roswell Park Comprehensive…

Mar 31, 2024, 23:13 | Blog

Sanam Loghavi: Thrilled to be represented by the best partner in editing

Sanam Loghavi, Associate Professor of Pathology and Laboratory Medicine at the Department of Hematopathology at…

Mar 31, 2024, 23:07 | Blog

Michael Wang: To my philanthropic donors, I am grateful for your support to further our attack on mantle cell lymphoma

Michael Wang, Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center,…

Jan 18, 2024, 15:38 | Blog

Yumeng Zhang: Moffitt Cutaneous Lymphoma Rack Card has arrived

Yumeng Zhang, Lymphoma Researcher and Clinician at Moffitt Cancer Center, shared on X/Twitter: “Moffitt Cutaneous…

Jan 9, 2024, 18:48 | Blog

Nico Gagelmann: Gastrointestinal (GI) manifestations in hematology

Nico Gagelmann, Co-Chair for the European Society for Blood and Marrow Transplantation (EBMT) Trainee Committee, shared…

Jan 9, 2024, 18:38 | Blog

Samantha Siegel: NEVER HUSTLE BACKWARDS, ALWAYS FORWARD

Samantha Siegel, a primary care doctor, cancer survivor and advocate, shared on LinkedIn: “Cancer Survivorship:…

Jan 3, 2024, 18:41 | Insight

Julie Vose: The long awaited publication from the NAMCL Project

Julie Vose shared a post on X/Twitter: ''Finally! The long awaited publication from the NAMCL Project!…

Dec 27, 2023, 17:10 | Blog

Julie Vose: She is a trooper and now sporting new hair and wearing lipstick!

Julie Vose shared a post by Nebraska Medicine on X/Twitter: "What a courageous strong woman!…

Oct 31, 2023, 23:19 | Blog

Bita Fakhri: Loved hearing these brilliant women in lymphoma openly sharing their career paths

Bita Fakhri, Hematologist and Oncologist at the Stanford Department of Medicine made the following post…

Oct 31, 2023, 10:22 | Insight

5 Decades of Impact reflection series - Australasian Leukaemia and Lymphoma Group

Australasian Leukaemia and Lymphoma Group (ALLG) shared on their LinkedIn: "To mark the start of…

Oct 18, 2023, 16:52 | Career

Ginna Laport: I joined CARGO Therapeutics as their Chief Medical Officer

Ginna Laport, Chief Medical Officer at CARGO Therapeutics, shared a post by CARGO Therapeutics on…

Oct 4, 2023, 17:41 | Insight

Elie G. Dib: Huge shout-out to Dr. Brad Zebrack for spearheading this innovative research exemplifying the future of survivorship science!

Quoting Elie G. Dib, Associate Director of The Haematology Oncology training program at Saint Joseph…

Aug 17, 2023, 16:33 | Blog

Amer Zeidan: It has been 16 years and 300 papers since my first paper was published in July 2007.

Amer Zeidan wrote in a recent tweet: ''It has been 16 years and 300 papers…

Aug 12, 2023, 16:19 | Drugs

Aaron Goodman: LOTIS-9 Trial in diffuse large B-cell lymphoma Pauses Enrollment Due to Respiratory Toxicities

In a post on Twitter by Aaron Goodman, Hematologist/Bone Marrow Transplanter at UCSD, it says,…

Aug 8, 2023, 05:07 | Blog

Sometimes in cancer, watchful waiting wins! - Dima Abla

Sometimes in cancer, watchful waiting wins! A new publication titled: Spontaneous remission of angioimmunoblastic T-cell…

Aug 6, 2023, 18:39 | Blog

Are you an early-stage scientist or clinician with an interest in paediatric and young adult non Hodgkin lymphoma? - Emily James

Are you an early-stage scientist or clinician with an interest in paediatric and young adult…

Jul 28, 2023, 20:23 | Drugs

What to do with Rituximab intolerant patients? - Timothy Voorhees

What to do with Rituximab intolerant patients? Don’t drop CD20 Ab therapy, switch to Obinutuzumab…

Jul 20, 2023, 17:15 | Blog

The scarcity of approvals in brain & head & neck - Jean-Charles Soria

FDA oncology approvals by disease site since 2000 illustrates ❶ the high number of approvals…

Jul 7, 2023, 06:00 | Career

Ann S. LaCasce, MD, MMSc (Dana-Farber) as Chair of LRF’s Scientific Advisory Board - Lymphoma Research Foundation

We're proud to welcome Ann S. LaCasce, MD, MMSc (Dana-Farber) as Chair of LRF’s Scientific…

Jul 4, 2023, 16:50 | Insight

Targeting CCR7-PI3Ky overcomes resistance to tyrosine kinase inhibitors AKL-rearranged lymphoma - Marco Campisi

I am happy to share that one of my collaborative efforts is finally out in…

Jun 30, 2023, 18:19 | Positive

She’s a great example of what it means to survive and thrive - E. Anders Kolb

Throughout June, in commemoration of National Cancer Survivor Month, we at The Leukemia & Lymphoma Society have…

Jun 18, 2023, 16:32 | Drugs

FDA approved our new bispecific antibody for treating people with relapsed or refractory Diffuse Large B-cell Lymphoma

In a post by Alexander Hardy on Linkedin, it says, "I’m excited to share that…

Jun 16, 2023, 18:25 | Stories

Tracked roots of Sir Thomas Hodgkin

In a post by Gaurav Prakash on Twitter, it says, “A kind of pilgrimage for…

lymphoma

OncoDaily

lymphoma